BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28265583)

  • 1. Clinical Outcomes of Specific Immunotherapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.
    Chen J; Xiao-Zhong G; Qi XS
    J Immunol Res; 2017; 2017():8282391. PubMed ID: 28265583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
    Amedei A; Niccolai E; Prisco D
    Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary analysis for clinical efficacy of immunotherapy in patients with pancreatic cancer.
    Chen L; Zhang X
    Immunotherapy; 2016 Feb; 8(2):223-34. PubMed ID: 26565954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells engineered to secrete anti-DcR3 antibody augment cytotoxic T lymphocyte response against pancreatic cancer
    Chen J; Guo XZ; Li HY; Zhao JJ; Xu WD
    World J Gastroenterol; 2017 Feb; 23(5):817-829. PubMed ID: 28223726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is recent in pancreatic cancer immunotherapy?
    Niccolai E; Prisco D; D'Elios MM; Amedei A
    Biomed Res Int; 2013; 2013():492372. PubMed ID: 23509731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of recombinant GA733-2E antigen (CO17-1A, EGP, KS1-4, KSA, Ep-CAM) in gastro-intestinal carcinoma patients.
    Staib L; Birebent B; Somasundaram R; Purev E; Braumüller H; Leeser C; Küttner N; Li W; Zhu D; Diao J; Wunner W; Speicher D; Beger HG; Song H; Herlyn D
    Int J Cancer; 2001 Apr; 92(1):79-87. PubMed ID: 11279610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for pancreatic cancer: A long and hopeful journey.
    Xu JW; Wang L; Cheng YG; Zhang GY; Hu SY; Zhou B; Zhan HX
    Cancer Lett; 2018 Jul; 425():143-151. PubMed ID: 29605510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in immunotherapy for pancreatic cancer: 2013.
    DeVito NC; Saif MW
    JOP; 2013 Jul; 14(4):347-53. PubMed ID: 23846925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tumor tolerance: A new hope for pancreatic cancer therapy?
    Delitto D; Wallet SM; Hughes SJ
    Pharmacol Ther; 2016 Oct; 166():9-29. PubMed ID: 27343757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for patients with advanced pancreatic carcinoma: a promising treatment.
    Zhang B; Dong Y; Liu J; Lian Z; Liang L; Chen W; Luo X; Pei S; Mo X; Zhang L; Huang W; Ouyang F; Guo B; Liang C; Zhang S
    Oncotarget; 2017 Jan; 8(4):5703-5716. PubMed ID: 27992378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer: Update on immunotherapies and algenpantucel-L.
    McCormick KA; Coveler AL; Rossi GR; Vahanian NN; Link C; Chiorean EG
    Hum Vaccin Immunother; 2016 Mar; 12(3):563-75. PubMed ID: 26619245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoprevention of Pancreatic Cancer.
    Rao CV; Mohammed A; Asch AS; Janakiram NB
    Curr Med Chem; 2018; 25(22):2576-2584. PubMed ID: 28240168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Q&A: Evidence presenter. Interview by Marian Turner.
    Palucka K
    Nature; 2013 Dec; 504(7480):S9. PubMed ID: 24352364
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of Tumor Vaccines and Cellular Immunotherapies in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Dammeijer F; Lievense LA; Veerman GD; Hoogsteden HC; Hegmans JP; Arends LR; Aerts JG
    J Clin Oncol; 2016 Sep; 34(26):3204-12. PubMed ID: 27432922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody CO17-1A and leukapheresis in immunotherapy of pancreatic cancer.
    Tempero MA; Pour PM; Uchida E; Herlyn D; Steplewski Z
    Hybridoma; 1986 Jul; 5 Suppl 1():S133-8. PubMed ID: 3744378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current topics and future to vaccine for pancreatic cancer].
    Miyazawa M; Yamaue H
    Nihon Jibiinkoka Gakkai Kaiho; 2013 May; 116(5):573-80. PubMed ID: 24024272
    [No Abstract]   [Full Text] [Related]  

  • 17. New targeted therapies in pancreatic cancer.
    Seicean A; Petrusel L; Seicean R
    World J Gastroenterol; 2015 May; 21(20):6127-45. PubMed ID: 26034349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapeutic approaches in pancreatic cancer.
    Stieler J
    Recent Results Cancer Res; 2008; 177():165-77. PubMed ID: 18084958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Algenpantucel-L immunotherapy in pancreatic adenocarcinoma.
    Coveler AL; Rossi GR; Vahanian NN; Link C; Chiorean EG
    Immunotherapy; 2016 Feb; 8(2):117-25. PubMed ID: 26787078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials of vaccines for immunotherapy in pancreatic cancer.
    Plate J
    Expert Rev Vaccines; 2011 Jun; 10(6):825-36. PubMed ID: 21692703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.